This study is testing a new procedure called Minimally Invasive Micro Sclerostomy (MIMS®) using a special device to lower eye pressure in people with open-angle glaucoma. This is for individuals whose eye pressure is not well-controlled even with multiple medications. The goal is to see if the MIMS® procedure is as successful at lowering eye pressure as a traditional surgery called trabeculectomy, both used with Mitomycin-C. You may be able to join if you are between 40 and 85 years old and have primary open-angle glaucoma with specific vision field changes and eye pressure between 21 and 40 mmHg. The study aims to measure the success rate of the MIMS® procedure 12 months after surgery. The current recruitment status is unclear.

Study design

This is a single-arm study planning to enroll 129 participants. It will compare the results of the MIMS® procedure to the known success rate of traditional trabeculectomy.

What's involved

Eligible participants will undergo the MIMS® procedure and will be followed for 12 months.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 12 months after the surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.